Cargando…
A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer
Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor receptor 2 (HER2)-negative tumors are referred to as having metastatic triple-negative breast cancer (mTNBC) disease. Although there have been many new treatment options ap...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807882/ https://www.ncbi.nlm.nih.gov/pubmed/27042088 http://dx.doi.org/10.4137/BCBCR.S32783 |